tetano
Editor, Senior Moderator
Biochem Genet
. 2023 May 15.
doi: 10.1007/s10528-023-10366-0. Online ahead of print. Bioinformatics Approach to Identify the Influences of COVID-19 on Ischemic Stroke
Jiabao Zhu[SUP] #[/SUP][SUP] 1 [/SUP], Xiangui Li[SUP] #[/SUP][SUP] 1 [/SUP], Fanzhen Lv[SUP] #[/SUP][SUP] 1 [/SUP], Weimin Zhou[SUP] 2 [/SUP]
Affiliations
As severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is becoming more infectious and less virulent, symptoms beyond the lungs of the Coronavirus Disease 2019 (COVID-19) patients are a growing concern. Studies have found that the severity of COVID-19 patients is associated with an increased risk of ischemic stroke (IS); however, the underlying pathogenic mechanisms remain unknown. In this study, bioinformatics approaches were utilized to explore potential pathogenic mechanisms and predict potential drugs that may be useful in the treatment of COVID-19 and IS. The GSE152418 and GSE122709 datasets were downloaded from the GEO website to obtain the common differentially expressed genes (DEGs) of the two datasets for further functional enrichment, pathway analysis, and drug candidate prediction. A total of 80 common DEGs were identified in COVID-19 and IS datasets for GO and KEGG analysis. Next, the protein-protein interaction (PPI) network was constructed and hub genes were identified. Further, transcription factor-gene interactions and DEGs-miRNAs coregulatory network were investigated to explore their regulatory roles in disease. Finally, protein-drug interactions with common DEGs were analyzed to predict potential drugs. We successfully identified the top 10 hub genes that could serve as novel targeted therapies for COVID-19 and screened out some potential drugs for the treatment of COVID-19 and IS.
Keywords: COVID-19; Differentially expressed genes; Drug molecule; Hub gene; Ischemic stroke; Thrombosis.
. 2023 May 15.
doi: 10.1007/s10528-023-10366-0. Online ahead of print. Bioinformatics Approach to Identify the Influences of COVID-19 on Ischemic Stroke
Jiabao Zhu[SUP] #[/SUP][SUP] 1 [/SUP], Xiangui Li[SUP] #[/SUP][SUP] 1 [/SUP], Fanzhen Lv[SUP] #[/SUP][SUP] 1 [/SUP], Weimin Zhou[SUP] 2 [/SUP]
Affiliations
- PMID: 37184686
- DOI: 10.1007/s10528-023-10366-0
As severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is becoming more infectious and less virulent, symptoms beyond the lungs of the Coronavirus Disease 2019 (COVID-19) patients are a growing concern. Studies have found that the severity of COVID-19 patients is associated with an increased risk of ischemic stroke (IS); however, the underlying pathogenic mechanisms remain unknown. In this study, bioinformatics approaches were utilized to explore potential pathogenic mechanisms and predict potential drugs that may be useful in the treatment of COVID-19 and IS. The GSE152418 and GSE122709 datasets were downloaded from the GEO website to obtain the common differentially expressed genes (DEGs) of the two datasets for further functional enrichment, pathway analysis, and drug candidate prediction. A total of 80 common DEGs were identified in COVID-19 and IS datasets for GO and KEGG analysis. Next, the protein-protein interaction (PPI) network was constructed and hub genes were identified. Further, transcription factor-gene interactions and DEGs-miRNAs coregulatory network were investigated to explore their regulatory roles in disease. Finally, protein-drug interactions with common DEGs were analyzed to predict potential drugs. We successfully identified the top 10 hub genes that could serve as novel targeted therapies for COVID-19 and screened out some potential drugs for the treatment of COVID-19 and IS.
Keywords: COVID-19; Differentially expressed genes; Drug molecule; Hub gene; Ischemic stroke; Thrombosis.